Variant report
Variant | esv3383479 |
---|---|
Chromosome Location | chr5:115129353-115131951 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:115130205..115131867-chr5:115132318..115134731,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186059189 | chr5:115130221-115130222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192125829 | chr5:115130227-115130228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs533953855 | chr5:115130244-115130245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs74927792 | chr5:115130283-115130284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148056231 | chr5:115130287-115130288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182295155 | chr5:115130290-115130291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs140864771 | chr5:115130311-115130312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77214203 | chr5:115130328-115130329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs79664962 | chr5:115130349-115130350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565237387 | chr5:115130351-115130352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138639401 | chr5:115130366-115130367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141791748 | chr5:115130371-115130372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561548915 | chr5:115130394-115130395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145053541 | chr5:115130404-115130405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138892663 | chr5:115130405-115130406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149346844 | chr5:115130411-115130412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs201992478 | chr5:115130468-115130469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376861089 | chr5:115130469-115130470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112999753 | chr5:115130470-115130471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186090078 | chr5:115130486-115130487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs527369904 | chr5:115130501-115130502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144661382 | chr5:115130584-115130585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148514407 | chr5:115130619-115130620 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs199564335 | chr5:115130803-115130804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs200616523 | chr5:115130804-115130805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201188878 | chr5:115130805-115130806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs200335178 | chr5:115130806-115130807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs35316891 | chr5:115130829-115130830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548747012 | chr5:115130840-115130841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536304916 | chr5:115130847-115130848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541186038 | chr5:115130884-115130885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567253750 | chr5:115130891-115130892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs258736 | chr5:115130906-115130907 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs258737 | chr5:115130926-115130927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190892560 | chr5:115130997-115130998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571481256 | chr5:115131007-115131008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs538806913 | chr5:115131027-115131028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs141973143 | chr5:115131039-115131040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs541347984 | chr5:115131049-115131050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150694564 | chr5:115131059-115131060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530325970 | chr5:115131099-115131100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573405467 | chr5:115131106-115131107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs249490 | chr5:115131150-115131151 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs249491 | chr5:115131158-115131159 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs140909622 | chr5:115131176-115131177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573929824 | chr5:115131192-115131193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113947378 | chr5:115131219-115131220 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs564344845 | chr5:115131240-115131241 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs80329030 | chr5:115131241-115131242 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs144869686 | chr5:115131283-115131284 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sezary syndrome | 18413736 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:115130200-115130400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:115130200-115130400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr5:115130200-115130400 | Enhancers | HepG2 | liver |
4 | chr5:115130400-115131200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr5:115130400-115131400 | Weak transcription | HepG2 | liver |
6 | chr5:115130400-115138400 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr5:115131200-115131400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr5:115131400-115132600 | Enhancers | Liver | Liver |
9 | chr5:115131400-115135400 | Enhancers | HepG2 | liver |
10 | chr5:115131400-115137800 | Weak transcription | Fetal Brain Female | brain |
11 | chr5:115131400-115149200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr5:115131600-115132200 | Enhancers | Placenta | Placenta |
13 | chr5:115131600-115134600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr5:115131800-115135200 | Enhancers | Adipose Nuclei | Adipose |
15 | chr5:115131800-115137800 | Weak transcription | Aorta | Aorta |